

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oxygen transport (GO:0015671) | 6.75771820 |
| 2 | hemoglobin metabolic process (GO:0020027) | 6.64685292 |
| 3 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.51680549 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.09208067 |
| 5 | gas transport (GO:0015669) | 5.57345142 |
| 6 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.14819776 |
| 7 | regulation of platelet aggregation (GO:0090330) | 5.10869869 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.90507463 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89222642 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.89222642 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89222642 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89222642 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89222642 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.89222642 |
| 15 | erythrocyte development (GO:0048821) | 4.87722297 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.86643069 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.86643069 |
| 18 | erythrocyte maturation (GO:0043249) | 4.62973047 |
| 19 | heme biosynthetic process (GO:0006783) | 4.54665739 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50582074 |
| 21 | positive regulation of granulocyte differentiation (GO:0030854) | 4.45819064 |
| 22 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.44472278 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38599342 |
| 24 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.27161423 |
| 25 | positive regulation of fibroblast migration (GO:0010763) | 4.26596064 |
| 26 | myeloid cell development (GO:0061515) | 4.20654791 |
| 27 | neutrophil activation (GO:0042119) | 4.16013622 |
| 28 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.96300261 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93718071 |
| 30 | modulation by virus of host process (GO:0019054) | 3.86085952 |
| 31 | tetrapyrrole biosynthetic process (GO:0033014) | 3.83532493 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.83078398 |
| 33 | detection of other organism (GO:0098543) | 3.82377103 |
| 34 | granulocyte activation (GO:0036230) | 3.81154031 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81066113 |
| 36 | microglial cell activation (GO:0001774) | 3.78943741 |
| 37 | detection of bacterium (GO:0016045) | 3.73679176 |
| 38 | hepatocyte apoptotic process (GO:0097284) | 3.71779719 |
| 39 | porphyrin-containing compound metabolic process (GO:0006778) | 3.71446388 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67617129 |
| 41 | response to peptidoglycan (GO:0032494) | 3.66037229 |
| 42 | megakaryocyte development (GO:0035855) | 3.64696869 |
| 43 | heme metabolic process (GO:0042168) | 3.64449751 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.56326218 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.52000751 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49952211 |
| 47 | response to host immune response (GO:0052572) | 3.49952211 |
| 48 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.49389253 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.48295417 |
| 50 | leukocyte degranulation (GO:0043299) | 3.47357295 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43461816 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 3.42167304 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.39878040 |
| 54 | cellular extravasation (GO:0045123) | 3.39220068 |
| 55 | myeloid cell activation involved in immune response (GO:0002275) | 3.36835775 |
| 56 | modulation by symbiont of host cellular process (GO:0044068) | 3.36112012 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33224246 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30916421 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.29684076 |
| 60 | leukocyte aggregation (GO:0070486) | 3.29158898 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.27464065 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 3.26667535 |
| 63 | response to interleukin-15 (GO:0070672) | 3.21984690 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.21579232 |
| 65 | definitive hemopoiesis (GO:0060216) | 3.19853003 |
| 66 | regulation of granulocyte differentiation (GO:0030852) | 3.19805095 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18264668 |
| 68 | response to host (GO:0075136) | 3.18264668 |
| 69 | response to host defenses (GO:0052200) | 3.18264668 |
| 70 | cellular response to virus (GO:0098586) | 3.17479332 |
| 71 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15184832 |
| 72 | regulation of platelet activation (GO:0010543) | 3.12957702 |
| 73 | detection of external biotic stimulus (GO:0098581) | 3.12566652 |
| 74 | respiratory burst (GO:0045730) | 3.10042182 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07721274 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05965848 |
| 77 | neutrophil mediated immunity (GO:0002446) | 3.05903245 |
| 78 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.05493636 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04601150 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 3.03361077 |
| 81 | regulation of B cell differentiation (GO:0045577) | 3.02421396 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96230922 |
| 83 | macrophage activation (GO:0042116) | 2.95769508 |
| 84 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95393904 |
| 85 | regulation of response to osmotic stress (GO:0047484) | 2.94516853 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 2.86795518 |
| 87 | regulation of erythrocyte differentiation (GO:0045646) | 2.86063655 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.85608558 |
| 89 | negative regulation of glial cell proliferation (GO:0060253) | 2.84137008 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 2.81506228 |
| 91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80215320 |
| 92 | tolerance induction (GO:0002507) | 2.78982302 |
| 93 | viral protein processing (GO:0019082) | 2.77568993 |
| 94 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.76029860 |
| 95 | cellular response to interleukin-15 (GO:0071350) | 2.75638904 |
| 96 | positive thymic T cell selection (GO:0045059) | 2.73371035 |
| 97 | platelet formation (GO:0030220) | 2.71540083 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 2.70376249 |
| 99 | granulocyte differentiation (GO:0030851) | 2.70309273 |
| 100 | negative regulation of stress fiber assembly (GO:0051497) | 2.68846721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.71401921 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.10793750 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.88009488 |
| 4 | GATA1_19941826_ChIP-Seq_K562_Human | 3.84666236 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.39236958 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.95297399 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93091345 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82364222 |
| 9 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.80730586 |
| 10 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.80103433 |
| 11 | GATA2_19941826_ChIP-Seq_K562_Human | 2.67369241 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66827288 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63737703 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61623645 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.55428322 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51398776 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.50407322 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.49213561 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.43118200 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.42148923 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38514057 |
| 22 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.37571933 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.36428978 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.30083623 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25313757 |
| 26 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.24250782 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22317710 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21897116 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18334002 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.14527693 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13055084 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.11904645 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11072091 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 2.08861534 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06624247 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05977194 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05425526 |
| 38 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.02999463 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.98606590 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89887421 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.89413336 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89321253 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88244092 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.85483902 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84899877 |
| 46 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.84861201 |
| 47 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81295900 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.80472219 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80231983 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78378858 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69956532 |
| 52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.67262143 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65743554 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65625613 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.65266011 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64611961 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63778135 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61732117 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59069336 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56142882 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55112194 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55071759 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52326533 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41102439 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35583576 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31886985 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29078993 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28910258 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27216250 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25129706 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24795202 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24056723 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20252479 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16571594 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16459196 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16264539 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15212637 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15176447 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14314576 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13866137 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13202505 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12932928 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10849759 |
| 84 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10798486 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06822462 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06025791 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05320099 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05080052 |
| 89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.03757389 |
| 90 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03513847 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00131841 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97550609 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95516960 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95350384 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95070284 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92949230 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91320642 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90038920 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89439495 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87289086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.53254589 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 4.39554363 |
| 3 | MP0003724_increased_susceptibility_to | 3.99169404 |
| 4 | MP0003303_peritoneal_inflammation | 3.75316877 |
| 5 | MP0003436_decreased_susceptibility_to | 3.43442587 |
| 6 | MP0005083_abnormal_biliary_tract | 3.27059638 |
| 7 | MP0004147_increased_porphyrin_level | 2.89742246 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.77921410 |
| 9 | MP0008260_abnormal_autophagy | 2.52397771 |
| 10 | MP0002419_abnormal_innate_immunity | 2.49175048 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.46699980 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.46699980 |
| 13 | MP0002132_abnormal_respiratory_system | 2.38358553 |
| 14 | MP0005025_abnormal_response_to | 2.33217482 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.27212249 |
| 16 | MP0000685_abnormal_immune_system | 2.27017753 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.26530696 |
| 18 | MP0002398_abnormal_bone_marrow | 2.18301389 |
| 19 | MP0001800_abnormal_humoral_immune | 2.17694453 |
| 20 | MP0001790_abnormal_immune_system | 2.16712543 |
| 21 | MP0005387_immune_system_phenotype | 2.16712543 |
| 22 | MP0005671_abnormal_response_to | 2.13596063 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.13303132 |
| 24 | MP0001819_abnormal_immune_cell | 2.10577109 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.06426849 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.02578106 |
| 27 | MP0002723_abnormal_immune_serum | 2.01054133 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.00028107 |
| 29 | MP0008004_abnormal_stomach_pH | 1.97843577 |
| 30 | MP0002405_respiratory_system_inflammati | 1.94705609 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.94413471 |
| 32 | MP0009278_abnormal_bone_marrow | 1.94188173 |
| 33 | MP0009785_altered_susceptibility_to | 1.91923378 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.90850496 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.82746338 |
| 36 | MP0006082_CNS_inflammation | 1.79919061 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.78644991 |
| 38 | MP0002722_abnormal_immune_system | 1.77939327 |
| 39 | MP0003866_abnormal_defecation | 1.68815368 |
| 40 | MP0000716_abnormal_immune_system | 1.68025669 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.67360208 |
| 42 | MP0002429_abnormal_blood_cell | 1.63477408 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.62206928 |
| 44 | MP0004947_skin_inflammation | 1.59077663 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.57448480 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.51261826 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.49206602 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.48924831 |
| 49 | MP0003828_pulmonary_edema | 1.46154520 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.43055941 |
| 51 | MP0001851_eye_inflammation | 1.40950152 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.37548372 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.37006775 |
| 54 | MP0009764_decreased_sensitivity_to | 1.34240697 |
| 55 | MP0005310_abnormal_salivary_gland | 1.30426816 |
| 56 | MP0005451_abnormal_body_composition | 1.28039588 |
| 57 | MP0004510_myositis | 1.22486914 |
| 58 | MP0001663_abnormal_digestive_system | 1.17221365 |
| 59 | MP0000858_altered_metastatic_potential | 1.14957803 |
| 60 | MP0004381_abnormal_hair_follicle | 1.13729229 |
| 61 | MP0000343_altered_response_to | 1.13200262 |
| 62 | MP0000490_abnormal_crypts_of | 1.12116059 |
| 63 | MP0008469_abnormal_protein_level | 1.07909952 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.06497624 |
| 65 | MP0003878_abnormal_ear_physiology | 1.06497624 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.99840723 |
| 67 | MP0009763_increased_sensitivity_to | 0.98835886 |
| 68 | MP0001873_stomach_inflammation | 0.96085161 |
| 69 | MP0004130_abnormal_muscle_cell | 0.95801617 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.93868747 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.92810101 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 0.91835350 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.91832025 |
| 74 | MP0008874_decreased_physiological_sensi | 0.90998173 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.90455276 |
| 76 | MP0003075_altered_response_to | 0.87207541 |
| 77 | MP0004883_abnormal_blood_vessel | 0.86491175 |
| 78 | MP0003186_abnormal_redox_activity | 0.81613339 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.80735532 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.79384496 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.76938566 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.75163973 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.74642595 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.70318603 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.69282350 |
| 86 | MP0009931_abnormal_skin_appearance | 0.68791689 |
| 87 | MP0005381_digestive/alimentary_phenotyp | 0.68311903 |
| 88 | MP0005164_abnormal_response_to | 0.66843121 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.64293488 |
| 90 | MP0000249_abnormal_blood_vessel | 0.62667410 |
| 91 | MP0003045_fibrosis | 0.60984059 |
| 92 | MP0005166_decreased_susceptibility_to | 0.58162823 |
| 93 | MP0003795_abnormal_bone_structure | 0.55327165 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.54725197 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.52872380 |
| 96 | MP0000313_abnormal_cell_death | 0.52391498 |
| 97 | MP0008995_early_reproductive_senescence | 0.51814178 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.51140651 |
| 99 | MP0001915_intracranial_hemorrhage | 0.50953441 |
| 100 | MP0005390_skeleton_phenotype | 0.50861866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.89988553 |
| 2 | Prolonged bleeding time (HP:0003010) | 6.89843848 |
| 3 | Hypochromic anemia (HP:0001931) | 6.27312008 |
| 4 | Microcytic anemia (HP:0001935) | 5.78674280 |
| 5 | Poikilocytosis (HP:0004447) | 5.29247086 |
| 6 | Petechiae (HP:0000967) | 5.19913691 |
| 7 | Abnormal platelet volume (HP:0011876) | 4.86371396 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.75974659 |
| 9 | Epistaxis (HP:0000421) | 4.53604986 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.49843978 |
| 11 | Gingival bleeding (HP:0000225) | 4.27215178 |
| 12 | Abnormal hemoglobin (HP:0011902) | 4.27207420 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.25342355 |
| 14 | Increased mean platelet volume (HP:0011877) | 4.24087117 |
| 15 | Stomatitis (HP:0010280) | 4.23479137 |
| 16 | Purpura (HP:0000979) | 4.13932101 |
| 17 | Abnormality of macrophages (HP:0004311) | 4.11271720 |
| 18 | Myositis (HP:0100614) | 3.91039229 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.89185922 |
| 20 | Menorrhagia (HP:0000132) | 3.86212396 |
| 21 | Urticaria (HP:0001025) | 3.62137893 |
| 22 | Obstructive lung disease (HP:0006536) | 3.59423713 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.59423713 |
| 24 | Polycythemia (HP:0001901) | 3.57417225 |
| 25 | Cholelithiasis (HP:0001081) | 3.56285108 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51625568 |
| 27 | Acanthocytosis (HP:0001927) | 3.42664938 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.39481130 |
| 29 | Orchitis (HP:0100796) | 3.39357800 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.33223797 |
| 31 | Reticulocytosis (HP:0001923) | 3.27000219 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22694229 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17532701 |
| 34 | Abnormal gallbladder morphology (HP:0012437) | 3.16818332 |
| 35 | Encephalitis (HP:0002383) | 3.03031456 |
| 36 | Optic neuritis (HP:0100653) | 2.99683186 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 2.99683186 |
| 38 | Episodic fever (HP:0001954) | 2.97921258 |
| 39 | Abnormal platelet function (HP:0011869) | 2.92849980 |
| 40 | Impaired platelet aggregation (HP:0003540) | 2.92849980 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.90241074 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.88999053 |
| 43 | Toxemia of pregnancy (HP:0100603) | 2.88516187 |
| 44 | Abnormality of iron homeostasis (HP:0011031) | 2.84948662 |
| 45 | Meningitis (HP:0001287) | 2.84825696 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.84603363 |
| 47 | Increased IgE level (HP:0003212) | 2.79923377 |
| 48 | Recurrent skin infections (HP:0001581) | 2.74687876 |
| 49 | Pustule (HP:0200039) | 2.72640658 |
| 50 | Increased serum ferritin (HP:0003281) | 2.59370646 |
| 51 | Cellulitis (HP:0100658) | 2.58289713 |
| 52 | Gingivitis (HP:0000230) | 2.58283859 |
| 53 | Slow saccadic eye movements (HP:0000514) | 2.57611211 |
| 54 | Increased IgM level (HP:0003496) | 2.56042221 |
| 55 | Chest pain (HP:0100749) | 2.53615918 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.50505268 |
| 57 | Vasculitis (HP:0002633) | 2.49387381 |
| 58 | Paralysis (HP:0003470) | 2.45527941 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.43702017 |
| 60 | Leukocytosis (HP:0001974) | 2.43470683 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.41305319 |
| 62 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.40269100 |
| 63 | Cholecystitis (HP:0001082) | 2.38128166 |
| 64 | Abnormal gallbladder physiology (HP:0012438) | 2.38128166 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35063798 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35063798 |
| 67 | Osteomyelitis (HP:0002754) | 2.33803783 |
| 68 | Bruising susceptibility (HP:0000978) | 2.25649800 |
| 69 | Anorexia (HP:0002039) | 2.23199433 |
| 70 | Keratoconjunctivitis (HP:0001096) | 2.22452793 |
| 71 | Abnormality of the gallbladder (HP:0005264) | 2.20401199 |
| 72 | Hematochezia (HP:0002573) | 2.17851443 |
| 73 | Arterial thrombosis (HP:0004420) | 2.16985516 |
| 74 | Granulocytopenia (HP:0001913) | 2.13647617 |
| 75 | Recurrent viral infections (HP:0004429) | 2.10788623 |
| 76 | Severe visual impairment (HP:0001141) | 2.04384339 |
| 77 | Abnormality of T cells (HP:0002843) | 2.03379708 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 10.0588878 |
| 79 | Hepatosplenomegaly (HP:0001433) | 1.99908421 |
| 80 | Cutaneous photosensitivity (HP:0000992) | 1.97950030 |
| 81 | T lymphocytopenia (HP:0005403) | 1.97771548 |
| 82 | Abnormality of T cell physiology (HP:0011840) | 1.96194017 |
| 83 | Peritonitis (HP:0002586) | 1.95933155 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 1.95505012 |
| 85 | Abnormality of T cell number (HP:0011839) | 1.89674552 |
| 86 | Abnormality of the fingertips (HP:0001211) | 1.89433023 |
| 87 | Increased density of long bones (HP:0006392) | 1.89254024 |
| 88 | Abnormality of reticulocytes (HP:0004312) | 1.87955548 |
| 89 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87815762 |
| 90 | Pulmonary embolism (HP:0002204) | 1.85523143 |
| 91 | Ileus (HP:0002595) | 1.81226370 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 1.80034150 |
| 93 | Pulmonary infiltrates (HP:0002113) | 1.79369127 |
| 94 | Visual hallucinations (HP:0002367) | 1.77695832 |
| 95 | Nasal polyposis (HP:0100582) | 1.74790715 |
| 96 | Diplopia (HP:0000651) | 1.71498599 |
| 97 | Abnormality of binocular vision (HP:0011514) | 1.71498599 |
| 98 | Postural instability (HP:0002172) | 1.71203182 |
| 99 | Colitis (HP:0002583) | 1.70720715 |
| 100 | Albinism (HP:0001022) | 1.68925377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.84034667 |
| 2 | MAP2K3 | 4.01545812 |
| 3 | GRK6 | 3.41112599 |
| 4 | TAOK1 | 3.28906407 |
| 5 | EIF2AK1 | 3.22707416 |
| 6 | MAP4K1 | 2.86860903 |
| 7 | TAOK2 | 2.78758958 |
| 8 | MAP3K11 | 2.76709092 |
| 9 | MAP3K3 | 2.75863726 |
| 10 | TNK2 | 2.49846290 |
| 11 | FES | 2.43786398 |
| 12 | ERN1 | 2.30896652 |
| 13 | IRAK4 | 2.12475142 |
| 14 | FGR | 2.00540066 |
| 15 | PRPF4B | 1.99500413 |
| 16 | BTK | 1.99018884 |
| 17 | BLK | 1.96812462 |
| 18 | SYK | 1.96279630 |
| 19 | ZAP70 | 1.92648637 |
| 20 | CSK | 1.84898453 |
| 21 | HCK | 1.84203374 |
| 22 | PTK2B | 1.80380102 |
| 23 | BMX | 1.78533312 |
| 24 | MAP3K1 | 1.55941806 |
| 25 | TYK2 | 1.46417618 |
| 26 | EPHB1 | 1.42465323 |
| 27 | SIK3 | 1.35024025 |
| 28 | MARK3 | 1.31380070 |
| 29 | JAK3 | 1.31151899 |
| 30 | LYN | 1.28188405 |
| 31 | TAOK3 | 1.23787974 |
| 32 | TEC | 1.23297405 |
| 33 | TXK | 1.21946909 |
| 34 | IKBKE | 1.19642327 |
| 35 | PIM1 | 1.10545832 |
| 36 | JAK2 | 1.08094469 |
| 37 | TBK1 | 1.02446531 |
| 38 | KSR2 | 1.01588471 |
| 39 | HIPK2 | 1.00582159 |
| 40 | PRKD2 | 1.00224956 |
| 41 | GRK5 | 0.98071812 |
| 42 | CSF1R | 0.97026064 |
| 43 | BMPR2 | 0.96446200 |
| 44 | DYRK3 | 0.96219974 |
| 45 | MARK2 | 0.94934702 |
| 46 | LCK | 0.90155307 |
| 47 | MAP3K5 | 0.90012846 |
| 48 | YES1 | 0.86025910 |
| 49 | PTK6 | 0.84678903 |
| 50 | IKBKB | 0.84188544 |
| 51 | MATK | 0.83522968 |
| 52 | ITK | 0.81909767 |
| 53 | TESK2 | 0.81493132 |
| 54 | SGK3 | 0.78839885 |
| 55 | PDK1 | 0.76401558 |
| 56 | TRIB3 | 0.74106152 |
| 57 | KIT | 0.70554009 |
| 58 | STK4 | 0.70279440 |
| 59 | DYRK1B | 0.68932634 |
| 60 | CLK1 | 0.68119845 |
| 61 | PDPK1 | 0.67305949 |
| 62 | CDK19 | 0.64486959 |
| 63 | SMG1 | 0.64456448 |
| 64 | SGK2 | 0.60319742 |
| 65 | STK11 | 0.60225802 |
| 66 | JAK1 | 0.55993233 |
| 67 | WNK1 | 0.55853189 |
| 68 | FYN | 0.54626629 |
| 69 | KSR1 | 0.53408157 |
| 70 | SIK2 | 0.53360266 |
| 71 | STK10 | 0.52895292 |
| 72 | MAP3K8 | 0.52575701 |
| 73 | PIK3CG | 0.52571591 |
| 74 | IRAK1 | 0.51337066 |
| 75 | IRAK2 | 0.50192302 |
| 76 | MAPK12 | 0.50030853 |
| 77 | STK38 | 0.46205821 |
| 78 | MAPKAPK2 | 0.45521221 |
| 79 | RPS6KC1 | 0.44046520 |
| 80 | RPS6KL1 | 0.44046520 |
| 81 | MAP3K7 | 0.42429266 |
| 82 | RAF1 | 0.39804338 |
| 83 | PRKCQ | 0.39716902 |
| 84 | RET | 0.37722042 |
| 85 | MAP3K2 | 0.37258025 |
| 86 | ICK | 0.37245426 |
| 87 | MAP3K6 | 0.36610468 |
| 88 | MAP2K4 | 0.36065975 |
| 89 | RPS6KA6 | 0.34226371 |
| 90 | LRRK2 | 0.34112627 |
| 91 | DAPK2 | 0.33333899 |
| 92 | MAP3K14 | 0.33012096 |
| 93 | TRPM7 | 0.24580018 |
| 94 | GSK3A | 0.23484207 |
| 95 | PRKG2 | 0.22966624 |
| 96 | MAP3K13 | 0.21745010 |
| 97 | MAPK7 | 0.21085712 |
| 98 | SIK1 | 0.20949073 |
| 99 | SGK494 | 0.20006609 |
| 100 | SGK223 | 0.20006609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malaria_Homo sapiens_hsa05144 | 3.11407427 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59628762 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 2.29277888 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25796238 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25169781 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15656799 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.13994647 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.05990786 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05246426 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96002964 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90282114 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.86883133 |
| 13 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.85571916 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.85311377 |
| 15 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.80483830 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.76897840 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76586675 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.73146310 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71811744 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64883572 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61950428 |
| 22 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.58531242 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.57053376 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49697623 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44248843 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39250106 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39091554 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38998401 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.38106859 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.36220570 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34682877 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27551249 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24317500 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.23489834 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21044174 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19547388 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19044102 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.18885828 |
| 39 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.11533211 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.09001612 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.08923655 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08922970 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.07005126 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.05904379 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05479167 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05138033 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04600208 |
| 48 | Endocytosis_Homo sapiens_hsa04144 | 1.04071408 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.02383052 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.00338771 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99017744 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97354113 |
| 53 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96735320 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95946047 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94300952 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90521813 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88715198 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87767355 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87621154 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.84431838 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83618045 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82062800 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80892589 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79906266 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79548345 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78032687 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75979966 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75180772 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73845381 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72505126 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72339489 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71088883 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70843966 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68423253 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65358390 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64652008 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63712534 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62922157 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.61345380 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61209407 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60604104 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60323516 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59346729 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58099399 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57198334 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55483994 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54730131 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54070329 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53183161 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53056237 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51947933 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.51592600 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50743601 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50427865 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48427914 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48102914 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46006036 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.45977511 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44595597 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.43508118 |

